000 | 01669 a2200433 4500 | ||
---|---|---|---|
005 | 20250516154301.0 | ||
264 | 0 | _c20130819 | |
008 | 201308s 0 0 eng d | ||
022 | _a1536-0075 | ||
024 | 7 |
_a10.1080/15265161.2013.794875 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDubljević, Veljko | |
245 | 0 | 0 |
_aProhibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults. _h[electronic resource] |
260 |
_bThe American journal of bioethics : AJOB _c2013 |
||
300 |
_a23-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmphetamine _xadministration & dosage |
650 | 0 | 4 |
_aAmphetamines _xadministration & dosage |
650 | 0 | 4 |
_aCentral Nervous System Stimulants _xadministration & dosage |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aInhalation |
650 | 0 | 4 |
_aMethylphenidate _xadministration & dosage |
650 | 0 | 4 |
_aNootropic Agents _xadministration & dosage |
650 | 0 | 4 | _aPersonal Autonomy |
650 | 0 | 4 |
_aPublic Policy _xlegislation & jurisprudence |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSubstance-Related Disorders _xetiology |
650 | 0 | 4 | _aTaxes |
650 | 0 | 4 | _aUnited States |
773 | 0 |
_tThe American journal of bioethics : AJOB _gvol. 13 _gno. 7 _gp. 23-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/15265161.2013.794875 _zAvailable from publisher's website |
999 |
_c22836639 _d22836639 |